Thursday, October 2, 2025 10/2/2025

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

Award Number: U2CCA252973
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/02/2020
PERIOD OF PERFORMANCE END DATE: 08/31/2027

Group Awards By:

View Award Description

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing - While sovereign American Indian and Alaskan Native (AI/AN) tribes and communities across the United States have distinct languages and cultures, there is one unfortunate characteristic they share: extremely poor cancer health outcomes. Compounded by lower rates of cancer screening and more limited access to healthcare, AI/AN are more often diagnosed at later stages of disease and have the poorest outcomes for all types of cancer when compared to any other population in the United States. While the cause of these poor cancer health outcomes is likely multifactorial, a potential and largely unexplored factor is variation in the molecular genetic profiles of cancers arising in AI/AN. AI/AN populations were strikingly understudied in The NIH Cancer Genome Atlas Project (TCGA), accounting for < 0.5% of the cancer patients studied from across the nation. Of the nearly 11,000 patients sequenced in TCGA, only 27 (0.25%) were identified as AI/AN. It is our hypothesis that through appropriate, respectful AI/AN participant and community engagement and comprehensive genomic sequencing, we will discover novel germline and somatic tumor mutations, differences in the spectrum and/or frequency of cancer-promoting mutations, and genome-wide mutational signatures reflective of distinct exposures. It is our goal to translate these discoveries to improved cancer screening, precision prevention, and therapeutic intervention for AI participants and their communities. These studies will contribute new knowledge that benefits all U.S. populations. In this PE-CGS Center, while all cancers are under study, we are focusing on the molecular characterization of cancers that occur with increased frequency or those which are associated with particularly poor outcomes in AI communities in the American Southwest including: gastrointestinal and hepatobiliary cancers (stomach, colorectal, pancreatic, liver, biliary tract); genitourinary cancers (kidney, prostate); and other hormone-dependent cancers (breast, ovarian cancers). Our Specific Aims are to develop respectful and trusted means to: 1) Engage AI participants (cancer patients, survivors), Tribal Advisory and Governance Committees, and communities in participatory research studies of the molecular characterization of cancer, particularly focusing on cancers that display striking differences in incidence and outcome in Tribal Nations in the Southwest; 2) Discover novel somatic and germline mutations and/or differences in the spectrum and frequency of cancer-promoting mutations, and genome-wide mutational signatures reflective of specific exposures in AI participants, relative to other U.S. populations; 3) Disseminate clinical grade sequencing results and knowledge gained directly to cancer patient participants and their healthcare providers for their beneficence, supported with genetic counseling and navigation to treatment; and 4) Share anonymized, deidentified data and knowledge gained to Tribal participants, Advisory Committees, leaders, and communities using respectful means of engagement and communication, and also with the broader scientific community through the NCI Genome Data Commons and publication of scientific results in accordance with NIH Data Sharing Policies and Tribal Data Use Agreements.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $3,660,577 )
2025	2025	UNIVERSITY OF NEW MEXICO	1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	001	5	9/8/2025	NON-COMPETING CONTINUATION	$3,660,577
2025	2024	UNIVERSITY OF NEW MEXICO	1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	4	3/13/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $3,660,577

Issue Date FY: 2024 ( Subtotal = $3,623,357 )
2024	2024	UNIVERSITY OF NEW MEXICO	1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	87131	BERNALILLO	USA	Cancer Cause and Prevention Research	003	4	9/19/2024	SUPPLEMENT FOR EXPANSION	$137,728
2024	2024	UNIVERSITY OF NEW MEXICO	1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	001	4	9/11/2024	NON-COMPETING CONTINUATION	$3,669,083
2024	2024	UNIVERSITY OF NEW MEXICO	1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	002	4	9/18/2024	NON-COMPETING CONTINUATION	-$183,454
2024	2023	UNIVERSITY OF NEW MEXICO	1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	3	11/29/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $3,623,357

Issue Date FY: 2023 ( Subtotal = $1,423,886 )
2023	2023	UNIVERSITY OF NEW MEXICO	1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	3	9/15/2023	NON-COMPETING CONTINUATION	$1,278,909
2023	2023	UNIVERSITY OF NEW MEXICO	1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	87131	BERNALILLO	USA	Cancer Cause and Prevention Research	002	3	9/19/2023	SUPPLEMENT FOR EXPANSION	$144,977
2023	2023	UNIVERSITY OF NEW MEXICO	1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	001	3	9/19/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,423,886

Issue Date FY: 2022 ( Subtotal = $3,822,903 )
2022	2022	UNIVERSITY OF NEW MEXICO	2500 MARBLE DR NE	ALBUQUERQUE	NM	87131	BERNALILLO	USA	Cancer Cause and Prevention Research	001	2	9/13/2022	SUPPLEMENT FOR EXPANSION	$144,977
2022	2022	UNIVERSITY OF NEW MEXICO	2500 MARBLE DR NE	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	2	9/8/2022	NON-COMPETING CONTINUATION	$3,677,926
														Subtotal = $3,822,903

Issue Date FY: 2021 ( Subtotal = $0 )
2021	2020	UNIVERSITY OF NEW MEXICO	2500 MARBLE DR NE	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	1	8/31/2021	NEW	$0
														Subtotal = $0

Issue Date FY: 2020 ( Subtotal = $3,701,064 )
2020	2020	UNIVERSITY OF NEW MEXICO	2500 MARBLE DR NE	ALBUQUERQUE	NM	87131	BERNALILLO	USA	21st Century Cures Act - Beau Biden Cancer Moonshot	000	1	9/2/2020	NEW	$3,701,064
														Subtotal = $3,701,064

Grand Total All Awards = $16,231,787

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

Award Number: U2CCA252973

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/02/2020

PERIOD OF PERFORMANCE END DATE: 08/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer